JP2016155880A5 - - Google Patents

Download PDF

Info

Publication number
JP2016155880A5
JP2016155880A5 JP2016116373A JP2016116373A JP2016155880A5 JP 2016155880 A5 JP2016155880 A5 JP 2016155880A5 JP 2016116373 A JP2016116373 A JP 2016116373A JP 2016116373 A JP2016116373 A JP 2016116373A JP 2016155880 A5 JP2016155880 A5 JP 2016155880A5
Authority
JP
Japan
Prior art keywords
use according
delivery vehicle
medicament
ethanol
vasoconstrictor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016116373A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016155880A (ja
JP6473103B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016155880A publication Critical patent/JP2016155880A/ja
Publication of JP2016155880A5 publication Critical patent/JP2016155880A5/ja
Application granted granted Critical
Publication of JP6473103B2 publication Critical patent/JP6473103B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2016116373A 2005-06-17 2016-06-10 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法 Expired - Lifetime JP6473103B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69157105P 2005-06-17 2005-06-17
US60/691,571 2005-06-17

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015039086A Division JP6348437B2 (ja) 2005-06-17 2015-02-27 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018190933A Division JP2018203788A (ja) 2005-06-17 2018-10-09 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法

Publications (3)

Publication Number Publication Date
JP2016155880A JP2016155880A (ja) 2016-09-01
JP2016155880A5 true JP2016155880A5 (cg-RX-API-DMAC10.html) 2017-07-06
JP6473103B2 JP6473103B2 (ja) 2019-02-20

Family

ID=37570784

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2008517201A Expired - Lifetime JP5756250B2 (ja) 2005-06-17 2006-06-19 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法
JP2015039086A Expired - Lifetime JP6348437B2 (ja) 2005-06-17 2015-02-27 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法
JP2016116373A Expired - Lifetime JP6473103B2 (ja) 2005-06-17 2016-06-10 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法
JP2018190933A Withdrawn JP2018203788A (ja) 2005-06-17 2018-10-09 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2008517201A Expired - Lifetime JP5756250B2 (ja) 2005-06-17 2006-06-19 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法
JP2015039086A Expired - Lifetime JP6348437B2 (ja) 2005-06-17 2015-02-27 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018190933A Withdrawn JP2018203788A (ja) 2005-06-17 2018-10-09 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法

Country Status (15)

Country Link
US (4) US8114914B2 (cg-RX-API-DMAC10.html)
EP (2) EP1890732B1 (cg-RX-API-DMAC10.html)
JP (4) JP5756250B2 (cg-RX-API-DMAC10.html)
CN (3) CN101198362B (cg-RX-API-DMAC10.html)
AU (1) AU2006261358B2 (cg-RX-API-DMAC10.html)
CA (1) CA2611496C (cg-RX-API-DMAC10.html)
DK (2) DK1890732T3 (cg-RX-API-DMAC10.html)
ES (2) ES2675228T3 (cg-RX-API-DMAC10.html)
HK (1) HK1245143A1 (cg-RX-API-DMAC10.html)
HU (2) HUE038177T2 (cg-RX-API-DMAC10.html)
IL (2) IL191869A (cg-RX-API-DMAC10.html)
PL (2) PL2656860T3 (cg-RX-API-DMAC10.html)
PT (2) PT2656860T (cg-RX-API-DMAC10.html)
TR (1) TR201809015T4 (cg-RX-API-DMAC10.html)
WO (1) WO2006138691A1 (cg-RX-API-DMAC10.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
JP4681231B2 (ja) 2002-03-20 2011-05-11 マンカインド コーポレイション 吸入装置
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery
PT2656860T (pt) 2005-06-17 2021-07-28 Wisconsin Alumni Res Found Preparações vasoconstritoras tópicas e métodos para proteção de células durante a quimoterapia e a radioterapia do cancro
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
CN104383546B (zh) 2006-02-22 2021-03-02 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
US8785396B2 (en) * 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
MY155524A (en) 2008-06-13 2015-10-30 Mannkind Corp A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
EP2165706A1 (en) * 2008-09-18 2010-03-24 BioAlliance Pharma Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
AU2010259943C1 (en) 2009-06-12 2016-03-03 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
US20140343159A1 (en) * 2011-06-02 2014-11-20 Procertus Biopharm, Inc. Formulation of small adrenergic agonist salt forms in organic solvents
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
HK1201475A1 (en) 2011-10-24 2015-09-04 Mannkind Corporation Methods and compositions for treating pain
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
BR112015023168B1 (pt) 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
BR112017009980A2 (pt) 2014-11-14 2018-02-14 Follea Int ?sistema e método para prevenção de alopecia?.
WO2016201286A1 (en) 2015-06-11 2016-12-15 Applied Biology, Inc. Treatment of sexual dysfunction
EP3651767A1 (en) * 2017-07-14 2020-05-20 Galderma Research & Development Methods and compositions for reducing side effects in chemotherapeutic treatments
KR20200038506A (ko) * 2017-08-07 2020-04-13 핀치 테라퓨틱스, 인코포레이티드 건강한 장 장벽을 유지 및 회복시키기 위한 조성물 및 방법
EP3887351A4 (en) * 2018-11-27 2022-11-02 The Trustees of Columbia University in the City of New York COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATION OF FERROPTOSE AND TREATMENT OF EXCITOTOXIC DISORDERS
WO2021016081A1 (en) 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
WO2021084541A1 (en) * 2019-10-31 2021-05-06 Sol-Gel Technologies Ltd. Treatment of hair loss disorders with a topical egfr inhibitor
WO2023130086A1 (en) * 2021-12-31 2023-07-06 Jss Research, Llc Compositions and methods for topical treatment of vascular conditions
AU2022443966A1 (en) 2022-03-04 2024-08-22 Vasodynamics Limited Topical compositions and methods.
CN119313747B (zh) * 2024-12-17 2025-04-15 中国海洋大学三亚海洋研究院 一种鱼类表皮体色量化方法和装置

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2414918A (en) * 1941-09-23 1947-01-28 Abramson Harold Alexander Solutions for the improved nebulization therapy of the lungs and bronchioles
US2774789A (en) * 1947-10-24 1956-12-18 Sterling Drug Inc 1-arterenol and its acid-addition salts and preparation thereof
US2919230A (en) * 1953-10-29 1959-12-29 Rohm & Haas Hydrophilic base therapeutic compositions comprising cation-exchange resin
BE555319A (cg-RX-API-DMAC10.html) * 1956-03-21 1900-01-01
US3039922A (en) * 1959-08-17 1962-06-19 Carter Prod Inc Method of administering tablets having decongestant and anti-histaminic activity
US3134720A (en) * 1962-06-27 1964-05-26 Bristol Myers Co Medicated gels
US3574859A (en) * 1968-07-05 1971-04-13 Carl M Kosti Process for the treatment of hypertrophied gums
GB2122892B (en) * 1982-07-02 1986-01-29 Squibb & Sons Inc Nystantin pastille formulation
SE457055B (sv) 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
US4853216A (en) * 1987-04-02 1989-08-01 Bristol-Myers Company Process and composition for the topical application of alpha1 adrenergic agonist for pilomotor effects
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
US5013716A (en) 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
US5461042A (en) * 1988-12-30 1995-10-24 Loria; Roger M. Regulation of the immune system
US5374645A (en) * 1990-01-22 1994-12-20 Ciba-Geigy Corporation Transdermal administation of ionic pharmaceutically active agents via aqueous isopropanol
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
JPH04327533A (ja) 1991-04-23 1992-11-17 Lion Corp 抗アレルギー用粘膜局所投与剤
US5534242A (en) 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
US5585398A (en) * 1994-07-15 1996-12-17 Ernst; Amy A. Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
NL9401183A (nl) 1994-07-19 1996-03-01 Nederland Ptt Modulator/demodulatorinrichting voor koppeling van een dataterminal met een zend/ontvanginrichting, alsmede werkwijzen voor het tot stand brengen van een dataverbinding tussen een eerste en een tweede modulator/demodulatorinrichting.
GB9422571D0 (en) 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
CA2154979A1 (en) 1995-07-28 1997-01-29 Kenneth T. Armstrong Topical phenylephrine preparation
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
DE69735552T3 (de) 1996-12-23 2009-08-13 S.L.A. Pharma Ag Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz
GB2370989A (en) 2001-01-16 2002-07-17 Btg Int Ltd Piperine analogues for the treatment of skin conditions
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
JP2001131085A (ja) * 1999-08-25 2001-05-15 Saitama Daiichi Seiyaku Kk 経皮・経粘膜吸収用の医薬組成物
PL204106B1 (pl) * 2000-02-28 2009-12-31 Pharmakodex Ltd Zestaw do dostarczania środka terapeutycznego
US6375982B1 (en) 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
US7510728B2 (en) 2000-10-06 2009-03-31 Takeda Pharmaceutical Company Limited Solid preparations
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US20030152637A1 (en) 2001-01-25 2003-08-14 Mark Chasin Local anesthetic, and method of use
DK1997478T3 (da) 2001-02-15 2013-12-09 Access Pharma Inc Flydende formuleringer til forebyggelse og behandling af slimhindesygdomme og -lidelser
US20040176359A1 (en) 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20020192273A1 (en) 2001-06-15 2002-12-19 Teri Buseman Therapeutic patch useful for the treatment of hemorrhoids
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
JP4544391B2 (ja) * 2001-12-28 2010-09-15 ライオン株式会社 眼科用組成物
US6919348B2 (en) * 2002-05-02 2005-07-19 Edward T. Wei Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
WO2005014524A2 (en) * 2003-08-07 2005-02-17 Wisconsin Alumni Research Foundation Amino thiol compounds and compositions for use in conjunction with cancer therapy
EP1656102A2 (en) 2003-08-21 2006-05-17 Transoral Pharmaceuticals, Inc. Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof
US20070219253A1 (en) * 2003-09-17 2007-09-20 Gul Balwani Decongestant / antihistaminic / expectorant compositions
WO2005102334A2 (en) 2004-04-13 2005-11-03 Alza Corporation Apparatus and method for transdermal delivery of fentany-based agents
PT2656860T (pt) * 2005-06-17 2021-07-28 Wisconsin Alumni Res Found Preparações vasoconstritoras tópicas e métodos para proteção de células durante a quimoterapia e a radioterapia do cancro

Similar Documents

Publication Publication Date Title
MX2021000376A (es) Composiciones tópicas para el alivio del dolor.
EA202190115A1 (ru) Пленочные составы, содержащие дексмедетомидин, и способы их получения
JP2017149726A5 (cg-RX-API-DMAC10.html)
NZ749192A (en) Ar+ breast cancer treatment methods
AR090349A1 (es) Terapia de combinacion para trastornos proliferativos, kit y uso
EA202090637A1 (ru) Способы применения дипивефрина
NZ714963A (en) Compositions and methods for treating anemia
DOP2018000196A (es) Metodos para tratar la depresion con antagonistas del receptor de orexina-2
MA32806B1 (fr) Thérapie de combinaison avec des peptides époxycétones
NZ604029A (en) Methods of treating bladder cancer
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
MY196869A (en) Cancer treatment combinations
CL2019002172A1 (es) Agente terapéutico para enfermedades del hígado.
AR096892A1 (es) Una combinación farmacéutica para el tratamiento del melanoma
CO6400184A2 (es) Formulaciones galénicas de compuestos orgánicos
HRP20120918T1 (hr) Aminopirazolski spoj
CO6280574A2 (es) Metodos para utilizar antagonistas de vasopresina con agentes de quimioterapia con antraciclina para reducir la cardiotoxicidad y/o para mejorar la supervivencia
DOP2016000003A (es) Formas de dosificación farmacéuticas estabilizadas que comprenden atrasentán
CO2022016153A2 (es) Inhibidores de il4i1 y métodos de uso
AR074793A1 (es) Composiciones farmaceuticas liquidas que comprenden triptan y xilitol para tratar la migrana
JP2014504636A5 (cg-RX-API-DMAC10.html)
MX2013001279A (es) Composicion farmaceutica con un inhibidor selectivo de la enzima fosfodiesterasa en forma de gel oral.
ES2563068T3 (es) Tratamiento de esclerosis múltiple (MS) con Campath-1H
CL2015003014A1 (es) Composición farmacéutica que comprende 0,5-5 mg de (11?,17?)-17-hidroxi-11-[4-(metilsulfonil)fenil]-17-(pentafluoroetil)estra-4,9-dien-3-ona; forma de dosificación oral; uso para tratar y/o prevenir una enfermedad ginecológica, tal como, fibroides en el útero, endometriosis o hemorragias menstruales excesivas.
MX2015009681A (es) Un medicamento combinado que comprende finilefrina y paracetamol.